Literature DB >> 9845107

In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides.

S M Hahn1, A M DeLuca, D Coffin, C M Krishna, J B Mitchell.   

Abstract

PURPOSE: The purpose of this study was to screen several water soluble nitroxides for in vivo radioprotection, to evaluate their pharmacology, and to measure the effect of nitroxides on systemic blood pressure as a means of exploring the mechanism of in vivo radioprotection. METHODS AND MATERIALS: A number of water soluble nitroxides were screened for in vivo radioprotection in C3H mice at a single radiation dose. Selected nitroxides were administered by the intraperitoneal route 10 minutes prior to a whole body radiation dose of 9 Gy. Electron paramagnetic resonance spectroscopy (EPR) was used to measure whole blood levels of nitroxides. The nitroxides were evaluated for effects on systemic blood pressure in C3H mice.
RESULTS: All of the nitroxides studied demonstrated radioprotection compared to saline-treated controls. The 6-membered piperidine ring nitroxides including Tempol were reduced to the inactive hydroxylamine rapidly over 10-20 minutes. The 5-membered ring nitroxides were reduced more slowly over time. The 5-membered ring 3-carbamoyl-PROXYL did not produce a substantial decrease in systemic blood pressure after intraperitoneal administration compared to the other nitroxides studied. 3-carbamoyl-PROXYL was further evaluated over a range of whole body radiation doses and was found to provide radioprotection.
CONCLUSION: All of the nitroxides studied provided radioprotection. In vivo radioprotection for all of the compounds except 3-carbamoyl-PROXYL may be at least partially explained by the induction of hypotension and bone marrow hypoxia. 3-carbamoyl-PROXYL provided in vivo radioprotection similar in magnitude to Tempol and had little effect on blood pressure compared to the other nitroxides. Other mechanisms for radioprotection, including scavenging of free radicals are likely. 3-carbamoyl-PROXYL should be evaluated further as a systemic radioprotector.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845107     DOI: 10.1016/s0360-3016(98)00317-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy.

Authors:  Zhentai Huang; Jianfei Jiang; Natalia A Belikova; Detcho A Stoyanovsky; Valerian E Kagan; Arlan H Mintz
Journal:  J Neurooncol       Date:  2010-09-12       Impact factor: 4.130

2.  [Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].

Authors:  Shuangyan Ye; Sisi Zeng; Mengqiu Huang; Jianping Chen; Xi Chen; Pengfei Xu; Qianli Wang; Wenwen Gao; Bingsheng Yang; Bingtao Hao; Wenhuan Huang; Qiuzhen Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

Review 3.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 4.  Nitroxides as cancer imaging agents.

Authors:  Ryan M Davis; James B Mitchell; Murali C Krishna
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

5.  A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator.

Authors:  Jianfei Jiang; Detcho A Stoyanovsky; Natalia A Belikova; Yulia Y Tyurina; Qing Zhao; Muhammad A Tungekar; Valentyna Kapralova; Zhentai Huang; Arlan H Mintz; Joel S Greenberger; Valerian E Kagan
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

Review 6.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

Review 7.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

Review 8.  The chemistry and biology of nitroxide compounds.

Authors:  Benjamin P Soule; Fuminori Hyodo; Ken-Ichiro Matsumoto; Nicole L Simone; John A Cook; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

9.  Free radical scavenger specifically prevents ischemic focal ventricular tachycardia.

Authors:  Dezhi Xing; Ashok K Chaudhary; Francis J Miller; James B Martins
Journal:  Heart Rhythm       Date:  2009-01-06       Impact factor: 6.343

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.